CRISPR THERAPEUTICS AG
Asset & Liabilities Breakdown
Asset Breakdown FY2018
Total Assets: $489.0M
Liabilities Breakdown FY2018
Total Liabilities: $96.8M
Asset Breakdown
Total Assets: $489.0M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $456.6M | 93.4% |
| Accounts Receivable | $88.0K | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $18.5M | 3.8% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $289.0K | 0.1% |
| Other Assets | $13.5M | 2.8% |
Liabilities Breakdown
Total Liabilities: $96.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $5.1M | 5.2% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $91.8M | 94.8% |